3B Blackbio

{
  "main_header": {
    "sid": 418147,
    "name": "3B Blackbio",
    "stock_name": "3B Blackbio",
    "full_name": "3B Blackbio DX Ltd",
    "name_url": "stocks-analysis/3b-blackbio",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,627.55",
    "chg": 28.75,
    "chgp": "1.8%",
    "dir": 1,
    "prev_price": "1,598.80",
    "mcapval": "1,393.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532067,
    "symbol": "",
    "ind_name": "Healthcare Services",
    "ind_code": 18,
    "indexname": "",
    "isin": "INE994E01018",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "3.2 k",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/3b-blackbio-418147-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "3B Blackbio DX Ltd’s Mixed Week: -2.39% Price, +1.51% Sensex Tell the Story",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltds-mixed-week--239-price-151-sensex-tell-the-story-3826692",
        "imagepath": "",
        "date": "2026-02-07 17:15:00",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Mixed technical signals emerge amid price momentum shift</p>\n                    <p><strong>3 Feb:</strong> Downgrade to Sell rating due to technical weakness and valuation concerns</p>\n                    <p><strong>4 Feb:</strong> Sideways momentum shift with mixed technical indicators</p>\n                    <p><strong>6 Feb:</strong> Q2 FY26 results show modest growth but premium valuation remains a concern</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,667.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-..."
      },
      {
        "title": "Are 3B Blackbio DX Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-3b-blackbio-dx-ltd-latest-results-good-or-bad-3824871",
        "imagepath": "",
        "date": "2026-02-06 19:26:02",
        "description": "The latest financial results for 3B Blackbio DX Ltd for the quarter ended September 2025 present a nuanced picture of the company's performance. The company reported net sales of ₹33.90 crores, reflecting a year-on-year growth of 16.30%. This growth, while positive, is notably lower than the previous year's growth rate of 51.98%, indicating a potential slowdown in revenue expansion. \n\nNet profit for the same quarter stood at ₹14.71 crores, which represents a marginal increase of 0.41% compared to the previous year, significantly down from an impressive 86.62% growth in the same quarter last year. This suggests challenges in maintaining profit growth despite a solid revenue base.\n\nThe operating profit margin, excluding other income, was reported at 43.45%, which shows a decline from 55.51% in the prior year. This compression in margin indicates rising operational costs or pricing pressures that the company m..."
      },
      {
        "title": "3B Blackbio DX Q2 FY26: Modest Growth Overshadowed by Premium Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/result-analysis/3b-blackbio-dx-q2-fy26-modest-growth-overshadowed-by-premium-valuation-concerns-3825016",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/3BBlackbioDX_quaterlyResult_3825016.png",
        "date": "2026-02-06 19:02:38",
        "description": "3B Blackbio DX Ltd., a small-cap healthcare services company formerly known as Kilpest India Ltd., reported a consolidated net profit of ₹14.71 crores for Q2 FY26, marking a modest sequential growth of 16.84% quarter-on-quarter but a marginal year-on-year increase of just 0.41%. The company's shares traded at ₹1,627.55 on February 6, 2026, gaining 1.80% following the results announcement, though the stock remains 22.50% below its 52-week high of ₹2,100.00."
      },
      {
        "title": "3B Blackbio DX Ltd Sees Mixed Technical Signals Amid Sideways Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-sees-mixed-technical-signals-amid-sideways-momentum-shift-3819587",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/3BBlackbioDXLtd_technicaldot_3819587.png",
        "date": "2026-02-04 08:02:10",
        "description": "3B Blackbio DX Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a 3.27% gain on 4 Feb 2026, the stock’s overall technical outlook remains cautious, with MarketsMOJO downgrading its mojo grade from Hold to Sell on 2 Feb 2026 amid mixed momentum cues."
      },
      {
        "title": "3B Blackbio DX Ltd Downgraded to Sell Amid Technical Weakness and Valuation Concerns",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-downgraded-to-sell-amid-technical-weakness-and-valuation-concerns-3817369",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/3BBlackbioDXLtd_mojoScore_3817369.png",
        "date": "2026-02-03 08:14:34",
        "description": "3B Blackbio DX Ltd, a key player in the Healthcare Services sector, has seen its investment rating downgraded from Hold to Sell as of 2 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, stagnant financial trends, and subdued quality scores, signalling caution for investors amid challenging market conditions."
      },
      {
        "title": "3B Blackbio DX Ltd Sees Mixed Technical Signals Amid Price Momentum Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-sees-mixed-technical-signals-amid-price-momentum-shift-3815328",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/3BBlackbioDXLtd_technicaldot_3815328.png",
        "date": "2026-02-02 08:01:55",
        "description": "3B Blackbio DX Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily moving averages and a 2.85% decline in share price, the stock’s longer-term indicators suggest a nuanced outlook for investors."
      },
      {
        "title": "3B Blackbio DX Ltd Gains 1.89%: Technical Momentum and Mixed Fundamentals Shape Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-gains-189-technical-momentum-and-mixed-fundamentals-shape-week-3813185",
        "imagepath": "",
        "date": "2026-01-31 17:09:53",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 27:</strong> Stock opens at Rs.1,590.20, down 2.83%</p>\n                    <p><strong>Jan 28:</strong> Strong rebound with 4.76% gain to Rs.1,665.90</p>\n                    <p><strong>Jan 29:</strong> Upgrade to Hold rating announced; stock dips 1.22%</p>\n                    <p><strong>Jan 30:</strong> Mild recovery with 1.33% gain to close at Rs.1,667.45</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,636.55</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.1,667.45</div><div..."
      },
      {
        "title": "3B Blackbio DX Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/3b-blackbio-dx-ltd-upgraded-to-hold-as-technicals-improve-amid-mixed-financials-3808873",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/3BBlackbioDXLtd_mojoScore_3808873.png",
        "date": "2026-01-29 08:11:00",
        "description": "3B Blackbio DX Ltd, a healthcare services company, has seen its investment rating upgraded from Sell to Hold by MarketsMOJO as of 28 January 2026. This change reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company’s fundamentals remain mixed, improved technical indicators and a stable financial position have prompted a more cautious but optimistic stance."
      },
      {
        "title": "3B Blackbio DX Ltd Shows Technical Momentum Shift Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/3b-blackbio-dx-ltd-shows-technical-momentum-shift-amid-mixed-indicator-signals-3808678",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/3BBlackbioDXLtd_technicaldot_3808678.png",
        "date": "2026-01-29 08:01:02",
        "description": "3B Blackbio DX Ltd, a key player in the Healthcare Services sector, has demonstrated a notable shift in price momentum, reflected in its recent technical indicators and market performance. After a period of sideways movement, the stock is now exhibiting mildly bullish trends, supported by a combination of weekly bullish signals and mixed monthly technicals, suggesting a cautious but optimistic outlook for investors."
      }
    ],
    "total": 266,
    "sid": "418147",
    "stock_news_url": "https://www.marketsmojo.com/news/3b-blackbio-dx-418147"
  },
  "announcements": [
    {
      "caption": "Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended On 31St December 2025.",
      "datetime": "30-Jan-2026",
      "details": "3B Blackbio Dx Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended on 31st December 2025.",
      "source": "BSE"
    },
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Jan-2026",
      "details": "Certificate under Reg.74(5) of SEBI (DP)Regulations 2018",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Dec-2025",
      "details": "Special Window for Re-lodgement of Transfer Requests of Physical Shares",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "3B Blackbio DX Ltd has declared <strong>40%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

3B Blackbio DX Ltd’s Mixed Week: -2.39% Price, +1.51% Sensex Tell the Story

2026-02-07 17:15:00

Key Events This Week

2 Feb: Mixed technical signals emerge amid price momentum shift

3 Feb: Downgrade to Sell rating due to technical weakness and valuation concerns

4 Feb: Sideways momentum shift with mixed technical indicators

6 Feb: Q2 FY26 results show modest growth but premium valuation remains a concern

Week Open

Rs.1,667.45

Read full news article

Are 3B Blackbio DX Ltd latest results good or bad?

2026-02-06 19:26:02

The latest financial results for 3B Blackbio DX Ltd for the quarter ended September 2025 present a nuanced picture of the company's performance. The company reported net sales of ₹33.90 crores, reflecting a year-on-year growth of 16.30%. This growth, while positive, is notably lower than the previous year's growth rate of 51.98%, indicating a potential slowdown in revenue expansion. Net profit for the same quarter stood at ₹14.71 crores, which represents a marginal increase of 0.41% compared to the previous year, significantly down from an impressive 86.62% growth in the same quarter last year. This suggests challenges in maintaining profit growth despite a solid revenue base. The operating profit margin, excluding other income, was reported at 43.45%, which shows a decline from 55.51% in the prior year. This compression in margin indicates rising operational costs or pricing pressures that the company m...

Read full news article

3B Blackbio DX Q2 FY26: Modest Growth Overshadowed by Premium Valuation Concerns

2026-02-06 19:02:38

3B Blackbio DX Ltd., a small-cap healthcare services company formerly known as Kilpest India Ltd., reported a consolidated net profit of ₹14.71 crores for Q2 FY26, marking a modest sequential growth of 16.84% quarter-on-quarter but a marginal year-on-year increase of just 0.41%. The company's shares traded at ₹1,627.55 on February 6, 2026, gaining 1.80% following the results announcement, though the stock remains 22.50% below its 52-week high of ₹2,100.00.

Read full news article

3B Blackbio DX Ltd Sees Mixed Technical Signals Amid Sideways Momentum Shift

2026-02-04 08:02:10

3B Blackbio DX Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend, reflecting a complex interplay of bullish and bearish signals across key indicators. Despite a 3.27% gain on 4 Feb 2026, the stock’s overall technical outlook remains cautious, with MarketsMOJO downgrading its mojo grade from Hold to Sell on 2 Feb 2026 amid mixed momentum cues.

Read full news article

3B Blackbio DX Ltd Downgraded to Sell Amid Technical Weakness and Valuation Concerns

2026-02-03 08:14:34

3B Blackbio DX Ltd, a key player in the Healthcare Services sector, has seen its investment rating downgraded from Hold to Sell as of 2 February 2026. This shift reflects a combination of deteriorating technical indicators, expensive valuation metrics, stagnant financial trends, and subdued quality scores, signalling caution for investors amid challenging market conditions.

Read full news article

3B Blackbio DX Ltd Sees Mixed Technical Signals Amid Price Momentum Shift

2026-02-02 08:01:55

3B Blackbio DX Ltd, a key player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Despite a recent downgrade in daily moving averages and a 2.85% decline in share price, the stock’s longer-term indicators suggest a nuanced outlook for investors.

Read full news article

3B Blackbio DX Ltd Gains 1.89%: Technical Momentum and Mixed Fundamentals Shape Week

2026-01-31 17:09:53

Key Events This Week

Jan 27: Stock opens at Rs.1,590.20, down 2.83%

Jan 28: Strong rebound with 4.76% gain to Rs.1,665.90

Jan 29: Upgrade to Hold rating announced; stock dips 1.22%

Jan 30: Mild recovery with 1.33% gain to close at Rs.1,667.45

Week Open

Rs.1,636.55

Week Close

Rs.1,667.45

Read full news article

3B Blackbio DX Ltd Upgraded to Hold as Technicals Improve Amid Mixed Financials

2026-01-29 08:11:00

3B Blackbio DX Ltd, a healthcare services company, has seen its investment rating upgraded from Sell to Hold by MarketsMOJO as of 28 January 2026. This change reflects a nuanced assessment across four key parameters: quality, valuation, financial trend, and technicals. While the company’s fundamentals remain mixed, improved technical indicators and a stable financial position have prompted a more cautious but optimistic stance.

Read full news article

3B Blackbio DX Ltd Shows Technical Momentum Shift Amid Mixed Indicator Signals

2026-01-29 08:01:02

3B Blackbio DX Ltd, a key player in the Healthcare Services sector, has demonstrated a notable shift in price momentum, reflected in its recent technical indicators and market performance. After a period of sideways movement, the stock is now exhibiting mildly bullish trends, supported by a combination of weekly bullish signals and mixed monthly technicals, suggesting a cautious but optimistic outlook for investors.

Read full news article

View All News